Waters M D, Stack H F, Jackson M A
US Environmental Protection Agency, Research Triangle Park, NC 27711, USA.
IARC Sci Publ. 1999(146):499-536.
The results of short-term tests for mutagenicity were first included in the IARC Monographs in the mid-1970s on the basis of the observation that most carcinogens are also mutagens, although not all mutagens are carcinogens. The experimental evidence at that time showed a strong correlation between mutagenicity and carcinogenicity and indicated that the short-term tests were useful for predicting carcinogenicity. Although the correlations have become weaker over the past 20 years, and with them the predictive value of short-term tests, such tests still provide vital information for identifying and understanding mechanisms involved in carcinogenicity. The results of short-term tests compiled in the US Environmental Protection Agency-IARC Genetic Activity Profile database over the past 12 years are summarized and reviewed here in relation to the classification of agents for carcinogenicity within the system used at IARC. The role of the information from short-term tests in making overall classifications of specific compounds in recent Monographs is discussed. The usefulness of data on three genetic end-points, gene mutation, chromosomal aberrations and aneuploidy, and the criteria for mutagenicity and lack of mutagenicity based on a 'defining set' of test results are examined. Recommendations are made for assessing chemicals on the basis of the strength of the evidence from short-term tests, and the implications of this approach for identifying putative mutational mechanisms of carcinogenicity are discussed.
短期致突变性测试结果于20世纪70年代中期首次被纳入国际癌症研究机构(IARC)专论中,这是基于以下观察结果:大多数致癌物也是诱变剂,尽管并非所有诱变剂都是致癌物。当时的实验证据表明致突变性与致癌性之间存在很强的相关性,并表明短期测试对于预测致癌性很有用。尽管在过去20年中这种相关性变弱了,短期测试的预测价值也随之降低,但此类测试仍然为识别和理解致癌作用机制提供了重要信息。本文总结并回顾了过去12年在美国环境保护局 - IARC遗传活性概况数据库中汇编的短期测试结果,这些结果与IARC所用系统内致癌物的分类有关。讨论了短期测试信息在近期专论中对特定化合物进行总体分类的作用。研究了关于三个遗传终点(基因突变、染色体畸变和非整倍体)的数据的有用性,以及基于一组“定义性”测试结果的致突变性和无致突变性标准。根据短期测试证据的强度对化学品评估提出了建议,并讨论了这种方法对于识别推定的致癌突变机制的意义。